Prevalence at enrollment and incidence rate of high-risk cervical HPV infections in 144 patients with SLE.
| High-risk | Preexisting infections† | Incident Infections† | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| HPV Types | Events | Persistent Infection | No. of Cleared Infections | Events | Only at Next-to-last/Last Visit | Transient Infection | Persistent Infection | Duration of Persistence, mo, mean (95% CI) | No. of Cleared Infections | Cumulative No. of Events |
| 16 | 4 | 1 | 4 | 7 | 2/1 | 1 | 3 | 18.4 (14.0–19.1) | 0 | 11 |
| 18 | 1 | 0 | 1 | 5 | 2/1 | 0 | 2 | 14.0 (6.1–14.0) | 0 | 6 |
| 31 | 0 | 0 | 0 | 1 | 0/0 | 0 | 1 | 13.5 | 0 | 1 |
| 33 | 2 | 0 | 2 | 2 | 1/0 | 0 | 1 | 13.5 | 0 | 4 |
| 39 | 1 | 1 | 1 | 3 | 2/0 | 0 | 1 | 14.2 | 0 | 4 |
| 45 | 2 | 0 | 2 | 1 | 1/0 | 0 | 0 | — | — | 3 |
| 51 | 2 | 0 | 2 | 3 | 0/0 | 0 | 3 | 12.4 (6.1–20.5) | 0/1** | 5 |
| 52 | 8 (3) | 4 (1) | 5 (2)/1 ** | 7 | 1/3 | 0 | 3 | 11.9 (6.1–13.8) | 0/1** | 15 |
| 53 | 2 (1) | 0 | 2 (1) | 3 | 0/0 | 0 | 3 | 13.5 (6.1–14.0) | 0/1** | 5 |
| 56 | 1 | 0 | 1 | 4 | 1/1 | 1 | 1 | 19.1 | 0 | 5 |
| 58 | 1 | 0 | 1 | 5 | 0/0 | 3 | 2 | 12.4 (6.5–12.4) | 0 | 6 |
| 66 | 2 | 1 | 2 | 4 | 1/1 | 1 | 1 | 6.0 | 0 | 6 |
| 68 | 2 | 0 | 2** | 0 | 0/0 | 0 | 0 | — | — | 2 |
| 82 | 0 | 0 | 0 | 1 | 0/0 | 0 | 1 | 6.0 | 0 | 1 |
| Total | 28 (4) | 7 (1) | 25 (3)/1** | 46 | 11/7 | 6 | 22 | 0/3** | 74 | |
↵† One patient can contribute toward more than 1 type of HIV infection.
* Each patient can contribute toward more than 1 episode of infection of the same type of HPV if there is reinfection after clearance.
↵** Number of episode(s) of persistent HPV infection until next-to-last visit. Number in parentheses indicates the number of baseline infections with loop electrosurgical excision procedure or cervical biopsy done. The number of persistent and cleared infections does not necessarily equal the total number of events of preexisting infection since a persistent infection could also be cleared. The total number of events for the incident infections equals the sum of the number of infections at the next-to-last or last visit, transient, and persistent infection. HPV: human papilloma virus.